Matthew D. Linden - Concepedia

Author

Matthew D. Linden

The University of Western Australia ORCID

Also Known As

Atsuhiro Sugidachi, M D Linden, M Linden, M Lindén, M. D. LINDEN, M. D. Linden, M. Linden, M. Lindén, M.D. LINDEN, M.D. Linden

114

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

The University of Western Australia University of Massachusetts Chan Medical School The University of Melbourne Royal Children's Hospital Murdoch Children's Research Institute

About

Matthew D. Linden is an author at The University of Western Australia specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.2K
2	Health Sciences	6	6	295
3	Public Health	3	3	214
4	Education	1	1	20
5	Engineering	1	1	15

Matthew D. Linden

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway Andrew L. Frelinger, Mark I. Furman, Matthew D. Linden, Circulation	2006	304
Critical Reviews in Clinical Laboratory Sciences Matthew D. Linden, Huyen Tran, Matthew D. Linden,	2012	219
Association of Cyclooxygenase-1-Dependent and -Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization Andrew L. Frelinger, Youfu Li, Matthew D. Linden, Circulation	2009	171
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization Mark I. Furman, Lori A. Krueger, Matthew D. Linden, Journal of the American College of Cardiology ThrombosisGlycoprotein Iib/iiiaBlood PlateletCell SignalingHematology	2004	133
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia Bethan Psaila, James B. Bussel, Andrew L. Frelinger, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisHematological MalignancyBone Marrow FailureBlood Platelet	2011	129
Indices of platelet activation and the stability of coronary artery disease Matthew D. Linden, M.I. Furman, Andrew L. Frelinger, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletAtherosclerosis	2007	117
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation Bethan Psaila, James B. Bussel, Matthew D. Linden, Blood	2012	109
Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’ Alan D. Michelson, Matthew D. Linden, M.I. Furman, Journal of Thrombosis and Haemostasis ThrombosisCardiovascular DiseasePlatelet ResponseMedicineBlood Platelet	2006	106
Aspirin ‘resistance’: role of pre‐existent platelet reactivity and correlation between tests Andrew L. Frelinger, Y. LI, Matthew D. Linden, Journal of Thrombosis and Haemostasis ThrombosisCardiovascular DiseaseBlood PlateletMedicinePre‐existent Platelet Reactivity	2008	88
Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity M.R. BARNARD, Matthew D. Linden, Andrew L. Frelinger, Journal of Thrombosis and Haemostasis InflammationThrombosisThrombopoiesisHealth SciencesBlood Platelet	2005	81

Page 1